Literature DB >> 7549308

Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH).

S M Pueschel1, G Annerén, R Durlach, J Flores, M Sustrová, I C Verma.   

Abstract

There are numerous clinical conditions observed in persons with Down syndrome, as described above, which should be taken into consideration in the course of their medical care and management. If provided with optimal medical services, pursuing specific evaluations and examinations, with a focus on preventive aspects and fostering well being in all areas of human functioning, the quality of life of individuals with Down syndrome can be enhanced significantly and their contribution to society substantial.

Entities:  

Mesh:

Year:  1995        PMID: 7549308     DOI: 10.1111/j.1651-2227.1995.tb13768.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  13 in total

Review 1.  Optimal care for children with Down syndrome in India.

Authors:  I C Verma; M Kabra; A K Gangakhedkar
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

2.  T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome.

Authors:  Georgios Tsilingaridis; Tülay Yucel-Lindberg; Thomas Modéer
Journal:  Clin Oral Investig       Date:  2011-01-08       Impact factor: 3.573

3.  Adults with Down's syndrome: the prevalence of complications and health care in the community.

Authors:  Alex Henderson; Sally A Lynch; Steve Wilkinson; Morag Hunter
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

4.  High positivity of anti-CCP antibodies in patients with Down syndrome.

Authors:  Renato M Nisihara; Thelma L Skare; Marília B G Silva; Iara T Messias-Reason; Nanci P Oliveira; Patricia T Fiedler; Shirley R R Utiyama
Journal:  Clin Rheumatol       Date:  2007-03-27       Impact factor: 2.980

5.  Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity.

Authors:  B Karlsson; J Gustafsson; G Hedov; S A Ivarsson; G Annerén
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

6.  Association between Antimicrobial Peptide Histatin 5 Levels and Prevalence of Candida in Saliva of Patients with Down Syndrome.

Authors:  Tomoko Komatsu; Kiyoko Watanabe; Nobushiro Hamada; Eva Helmerhorst; Frank Oppenheim; Masaichi Chang-Il Lee
Journal:  Antibiotics (Basel)       Date:  2021-04-26

7.  Down syndrome, paternal age and education: comparison of California and the Czech Republic.

Authors:  Dagmara Dzurova; Hynek Pikhart
Journal:  BMC Public Health       Date:  2005-06-17       Impact factor: 3.295

8.  Validation and application of health utilities index in Chinese subjects with down syndrome.

Authors:  Winnie Ka Yan Mok; Wilfred Hing-Sang Wong; Gary Tsz Kin Mok; Yoyo Wing Yiu Chu; Frederick Ka Wing Ho; Chun Bong Chow; Patrick Ip; Brian Hon-Yin Chung
Journal:  Health Qual Life Outcomes       Date:  2014-10-14       Impact factor: 3.186

9.  Low Rates of Preventive Healthcare Service Utilization Among Adolescents and Adults With Down Syndrome.

Authors:  Kristin M Jensen; Elizabeth J Campagna; Elizabeth Juarez-Colunga; Allan V Prochazka; Desmond K Runyan
Journal:  Am J Prev Med       Date:  2020-11-12       Impact factor: 5.043

10.  Ophthalmic disorders in adults with down syndrome.

Authors:  Sharon J Krinsky-McHale; Edmund C Jenkins; Warren B Zigman; Wayne Silverman
Journal:  Curr Gerontol Geriatr Res       Date:  2012-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.